In Vivo Accumulation of Regulatory T Cells using Eliglustat-Loaded Cryogels.

Scientists have demonstrated that eliglustat-loaded cryogels offer a simple yet effective biomaterial strategy to directly boost Treg cells in vivo, potentially providing a targeted method to treat various inflammatory and autoimmune diseases.